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Mutational Analysis of Xist and the X-inactivation Center 
By Leeanne Marie Goodrich 
 
Abstract 
In placental mammals, dosage compensation of the sex chromosomes is 
achieved through inactivation of one X chromosome in female cells. This X 
chromosome inactivation (XCI) requires tight developmental regulation to ensure all but 
one X chromosome is silenced.  
At the center of this process is Xist, a long non-coding RNA. Upon differentiation 
of a female cell, Xist spreads in cis to coat and silence the inactive X chromosome. 
While upregulation of Xist, has been shown to be sufficient for X inactivation to occur, 
no one has thoroughly investigated whether Xist is necessary for the establishment of X 
chromosome inactivation. In this thesis I provide evidence that Xist is not required for 
dosage compensation of the X chromosome during epiblast-like cell differentiation. This 
result suggests Xist-independent silencing mechanisms for this essential process may 
be in place.  
A 1-2 Mb region of the X chromosome, termed the X-inactivation center (Xic) is 
necessary in two copies for XCI to occur, indicating it is necessary for cells to count the 
number of X chromosomes present. I delete one copy of the putative 2 Mb Xic in male 
and female mouse embryonic stem cells and present evidence that this deletion is not 
well tolerated, suggesting that this region requires finer resolution mapping to identify 
the minimal element required for counting. 
 viii 
Finally, I finish with a review which elaborates on studies that enlighten our 
understanding of activators and repressors that control XCI. Our findings challenge 
existing dogmas in the field and provide the foundation for future work focused on 
uncovering the molecular mechanisms behind Xist-independent silencing of the X 
chromosome. 
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Chapter 1 
 
Introduction 
  
 2 
 
Sex chromosomes require dosage compensation 
In diploid organisms, one set of chromosomes is inherited from the mother and 
one set is inherited from the father. This results in a matched set of chromosomes, with 
the exception of the sex chromosomes, which does not form a matched pair. The sex 
chromosomes genetically determine the sex of the organism, but they typically differ in 
their size and content between the sexes. 
Various species of animals solve this problem of dosage compensation between 
the sexes in different ways. For example, Caenorhabditis elegans (worms) reduce the 
gene expression of the XX hermaphrodites on each X chromosome by half (Meyer et al. 
2005). Drosophila melanogaster (fruit flies) on the other hand, upregulates the gene 
expression of sole X in males by two-fold (Salz et al. 2011). Placental mammals, 
including mice and humans, take a different approach by undergoing X chromosome 
inactivation, where females randomly silence one of their two X chromosomes to give 
one active (Xa) and one inactive (Xi) chromosome (Lyon 1961). X chromosome 
inactivation is how female placental mammals balance the number of X-linked gene 
transcripts between the sexes.  
X chromosome inactivation provides a fascinating paradigm by which to study 
epigenetic regulation - how are two identical chromosomes in the nucleus managed to 
be treated completely differently? What is the cascade of events that must happen in 
order for silencing to occur, chromosome wide? How does a female cell sense the 
number of X chromosomes it has? Questions like these have captivated researchers for 
over 50 years. 
 3 
X chromosome inactivation - where and when? 
In mice, X inactivation happens in two waves during early development. The first 
wave of X inactivation is imprinted X inactivation, where the paternal X chromosome 
(Xp) is always the one to be silenced. In the cells that will give rise to the primitive 
endoderm and the trophectoderm, imprinted X inactivation of the Xp is maintained 
(West et al. 1977.). However, in the inner cell mass, which will form the embryo proper, 
the silent Xp is reactivated, and then these cells undergo a second wave of X 
inactivation, which is random (Lyon 1961) (Figure 1.1). This means either the maternal 
or the paternal X chromosome can be silenced. In a mouse, embryonic stem cells can 
be derived from the inner cell mass of the embryo. Because these mouse embryonic 
stem cells (mESCs) have not yet undergone X inactivation, female mESCs have two 
active X chromosomes and therefore provide a model system in which query X 
chromosome inactivation. X chromosome inactivation is triggered by the destabilization 
of naive identity and is therefore concomitant with differentiation (Martin et al. 1978). 
This means researchers can model X chromosome inactivation by differentiating 
mESCs ex vivo. 
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Figure 1.1. X inactivation occurs in early mammalian development. In vivo, random X 
inactivation occurs when cells in the inner cell mass differentiate into cells that form the epiblast. 
This occurs early in development, upon implantation of the blastocyst. 
 
Xist is a key regulator of X inactivation 
Translocations and truncations have revealed that a genetically defined region of 
the X chromosome needs to be present in two copies for cells to know that they are 
female (Brown et al. 1991). This region, called the X inactivation center (Xic), is 
estimated to be about 1-2 MB in length and includes a mix of non-coding RNAs, protein 
coding genes, and pseudogenes. 
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Within the Xic and at the heart of X inactivation is a ~15kb long non-coding RNA 
called X inactive specific transcript, or Xist. Xist is expressed on low levels from both 
active X chromosomes. When X inactivation gets triggered, Xist is massively 
upregulated on the X chromosome to be inactivated (Xi) and beings to coat the 
chromosome in cis (Brown et al. 1992).  
Xist has been shown to be sufficient for silencing in cis. If an inducible Xist 
transgene is inserted on an autosome or the sole X in male mESCs, Xist will begin to 
coat and silence surrounding cis sequences (Wutz et al. 2000). While it has been widely 
assumed Xist must be necessary for silencing, a rigorous study testing this hypothesis 
has yet to be done. 
Xist has an antisense transcript, Tsix, which is also a non-coding RNA. Tsix is 
expressed on both X chromosomes prior to differentiation, and upon X inactivation gets 
shut off (Lee et al. 1999). Tsix has been known to negatively regulate Xist (Monkhorst et 
al. 2008). Although Xist and Tsix are both non-coding RNAs, they are both spliced and 
polyadenylated. 
Steps of X inactivation: counting, choice, establishment, and maintenance 
The steps that are necessary for random X chromosome inactivation are thought 
to include: determination of the number of X chromosomes (counting), marking the X 
chromosomes for differential fates (choice), the initial silencing of the X chromosome 
designated for inactivation (establishment), and the stable propagation of the silent state 
to all progeny cells (maintenance) (Gendrel et al. 2014) (Figure 1.2). 
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Figure 1.2. Steps of X inactivation. Female cells (top) need to dosage compensation their X 
chromosomes, and need to count their X chromosomes, randomly choose one X chromosome 
to be silenced, establishing X inactivation and maintain the inactive X for all subsequent cell 
divisions. Male cells (bottom) do not need to undergo X inactivation. 
 
Due to a nondisjunction during meiosis, sperm or eggs may have no copies of 
the X chromosome, or more than one copy of the X chromosome. This can result in 
embryos with aneuploidy in the sex chromosomes (XO, XX, XXX, XXY). In the case of 
an XO karyotype, similar to males (XY), the cells do not undergo X inactivation, as 
doing so would result in silencing the sole X chromosome and subsequent cell death. In 
cases of more than one X chromosome (XX, XXX, XXY), cells silence all but one X 
chromosome upon differentiation (Monkhorst et al. 2008). This implies that there exists 
a mechanism to sense and count the number of X chromosomes a cell has.  
XaY
XaXa
No X 
Chromosome 
Inactivation
Counting
XaXa
Choice
XaXi
Silencing
Establishment
XaXi
Silencing
Maintenance
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Once a cell senses that two X chromosomes are present, one is randomly 
chosen and designated to be silenced. Heterozygous loss-of-function mutations in 
either Xist or Tsix cause non-random XCI, implicating these ncRNAs in choice. If one X 
chromosome lacks functional Tsix, that chromosome will always become the Xi (Lee et 
al. 1999). Conversely, if one X chromosome lacks functional Xist, that chromosome will 
always become the Xa (Marahrens et al. 1998). 
In female cells, once the X chromosomes are counted, and one X chromosome 
is randomly chosen to be silenced, the initial establishment of X inactivation occurs. Xist 
is the first, and most dramatic marker of initiation as it is transcriptionally upregulated 
and begins to spread and coat the chromosome in cis. Xist recruits epigenetic modifiers 
such as PRC2, a H3K27 methyltransferase, which deposit silencing marks on the 
chromatin of the Xi (Plath et al. 2003). 
Finally, once X inactivation has been established, the Xi needs to be maintained 
for all subsequent cell divisions. Xist has been shown to be dispensable for the 
maintenance of the inactive X, since deleting it in differentiated fibroblasts doesn’t affect 
the ability of the cells to preserve silencing (Csankovszki et al. 1999). Presumably this is 
because once Xist has recruited stable marks, the machinery maintains itself. 
While these steps are listed in a defined order, it has not been experimentally 
demonstrated which steps occur first. It is reasonable to speculate that some steps may 
occur concurrently. These steps provide a framework for better understanding and 
dissecting the molecular mechanisms behind the complex process of X inactivation. 
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Summary 
The following study is an investigation into how female mouse stem cells might 
differentiate and dosage compensate in the absence of Xist, a key regulator of X 
chromosome inactivation. In chapter 2, I query X chromosome inactivation in female 
mESCs lacking functional Xist. I show that during differentiation of ESCs into epiblast-
like cells, Xist knockout mESCs behave similarly to their wild type counterparts with 
regard to kinetics of X-linked gene silencing as observed by RNA-seq. I also show that 
of the genes that differ, they might be connected to sister chromatid cohesion, which 
ties into a previously proposed model for how X chromosomes might sense each other 
prior to the initiation of X inactivation. 
While the identification of the Xic provides some insight into counting, this step 
remains poorly understood on a molecular level. It is not known what kind of information 
must be present in two copies to allow up regulation of Xist on one X chromosome. In 
chapter 3 I use genome editing to delete one copy of the Xic in female mESCs and the 
sole copy of the Xic in male cells. I show that the Xic can be deleted transiently in male 
and female mESCs, but for reasons that are not understood, genomic instability 
prevents this deletion from stably propagating. 
I end with chapter 4, which is adapted from a review summarizing key thoughts 
to consider in XCI related to activators and repressors. Potential models and hypothesis 
for how this intriguing complex epigenetic phenomenon could be regulated are 
proposed. 
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Chapter Two 
 
Investigating the establishment of X chromosome 
inactivation in the absence of Xist 
  
 10 
 
Introduction 
In eutherian mammals, females transcriptionally silence one of their two X 
chromosomes to equalize dosage between the sexes in a process known as X 
chromosome inactivation (XCI) (Lyon 1961). This process happens early in 
development, during implantation of the blastocyst, and is concomitant with 
differentiation (Avner et al 2001). 
At the heart of this process lies a non-coding RNA, Xist, which becomes 
massively upregulated on the X chromosome to be silenced (Brown et al. 1992). Xist 
has been shown to be sufficient for transcriptionally silencing sequences in cis. Inducing 
Xist expression from a single transgene on an autosome leads to inactivation of 
autosomal genes in cis (Wutz et al. 2000). Xist has been shown to be dispensable for 
maintenance, as deleting it in differentiated fibroblasts leaves the inactive X unaffected 
(Csankovszki et al. 1999). Xist has been shown to be necessary for imprinted XCI in 
extra embryonic tissues, but few studies have specifically asked whether Xist is 
necessary for the establishment of random X chromosome inactivation that occurs in 
the embryo proper. 
A previous study created a female mouse line with the first three exons of Xist 
flanked by loxP sites (Yang et al. 2016). Cre recombinase was transcriptionally 
regulated by a Sox2 promoter, as to bypass the requirement of Xist for imprinted XCI. 
This study demonstrated that female pups lacking Xist survive to term, and the Xist 
mutants manage to dampen the expression of X-linked genes. However, some caveats 
with this experiment include a potential leaky Sox2-Cre promoter, residual expression of 
 11 
Xist in certain cell tissues, and possible survivorship bias of the cells that escaped 
perfectly timed Cre recombination. Another study created an Xist homozygous mESC 
cell line and showed Xist homozygous mutants are unable to silence a single gene, 
Huwe1, by RNA fluorescence in situ hybridization (FISH) upon differentiation ex vivo but 
did not investigate any other X-linked transcripts (Schulz et al. 2014). 
In this work, we robustly investigate whether Xist is necessary during the initial 
establishment of XCI, using the differentiation of ESCs to Epiblast-like cells as an ex 
vivo model. We, for the first time, query the onset of XCI at single cell resolution in 
female homozygous Xist mutant ESCs. We find similarities in the transcriptome kinetics 
of X-linked gene expression during differentiation as observed by bulk and single-cell 
RNA-seq. We also observe some genes behave similarly between mutants and wild 
type by FISH. Together these results suggest that Xist is not necessary for initial 
dosage compensation during epiblast-like differentiation in mESCs. 
 
Materials and methods 
 
Cell culture 
The mESC line LF2 and its derivatives were routinely passaged by standard 
methods in KO-DMEM, 10% FBS, 2 mM glutamine, 1X non-essential amino acids, 0.1 
mM b-mercaptoethanol and recombinant leukemia inhibitory factor.  
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Generation of mutant mouse embryonic stem cell lines 
mESC lines were derived using CRISPR-Cas9 genome editing. A guide RNA to 
the A repeat or Rex1 UTR region was cloned into the px459-Cas9-2A-Puro plasmid 
using published protocols (Ran et al., 2013). Templates for homology directed repair 
were amplified from Gene Blocks (IDT) (Tables S1 and S2). Plasmid and template were 
co-transfected into LF2 mESCs using FuGENE HD (Promega) according to 
manufacturer's protocol. After two days cells were selected with puromycin for 48 hours, 
then allowed to grow in antibiotic-free media. For Rex1-2A-GFP constructs, cells were 
monitored for GFP fluorescence (indicating homology directed repair) and fluorescent 
cells were isolated by FACS 1-2 weeks after transfection. For Neo or Hygro insertions, 
cells were monitored for antibiotic resistance and single cell clones were picked and 
expanded. All cell lines were propagated from single cells and correct insertion was 
confirmed by PCR genotyping (supp fig). 
 
EpiLC Differentiation 
To convert ESCs to EpiLCs, ESC lines were grown in 2i culture conditions 
(N2B27 medium consisting 50% DMEM/F12, 50% neurobasal media, 2 mM L-glutamine 
(GIBCO, #25030), 0.1 mM 2-mercaptoethanol (Sigma, #M7522), N2 supplement 
(Invitrogen #17502048), B27 supplement without Vitamin A (ThermoFisher #12587010), 
supplemented with 1 μM GSK3 inhibitor CHIR99021 (Axon Medchem #1386), 1 μM 
MEK inhibitor PD0325901 (Axon Medchem #2435), and 1000 U/ml LIF (made in house) 
in Geltrex (ThermoFisher A1413202) coated tissue culture dishes for 4 passages 
(Buecker et al., 2014; Hayashi et al., 2011). 
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To achieve EpiLC differentiation, cells were cultured in N2B27 medium supplemented 
with 10 ng/ml FGF2 (Peprotech 100-18B) and 20 ng/ml Activin A (Peprotech AF-120-
14E) in Geltrex (ThermoFisher A1413202)-coated tissue culture dishes for either 3, 4, or 
5 days. 
 
FISH 
Cells were harvested, resuspended to 500,000 cells/ml, and then cytospun onto 
glass slides at 800 rpm for 3 minutes. ells were then permeabilized through sequential 
treatment with ice-cold cytoskeletal extraction buffer (CSK:100 mM NaCl, 300 mM 
sucrose, 3 mM MgCl2, and 10 mM PIPES buffer, pH 6. 8) for 30 sec, ice-cold CSK 
buffer containing 0.4% Triton X-100 (Fisher Scientific, #EP151) for 30 sec, followed 
twice with ice-cold CSK for 30 sec each. Finally, cells were then fixed in 4% 
paraformaldehyde for 10 minutes and stored at -20C in 70% ethanol until use. 
 
The dsRNA FISH probes were made by randomly priming DNA templates using 
BioPrime DNA Labeling System (Invitrogen, #18094011). Probes were labeled with 
Fluorescein-12-dUTP or -UTP (Invitrogen) or Cy3-dCTP or –CTP (GE Healthcare). 
Probes were stored at -80C until use. 
 
Slides were dehydrated through 5 min incubations in 80%, 90%, and 100% 
ethanol solutions and air-dried. 2ul of probe was hybridized overnight on the slides in a 
humid chamber at 37C. The samples were then washed 3X for 5 min at 39C with 
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2XSSC/50% formamide, 3X for 5 min SSC, and 3X for 5 min with 1X SSC. A 1:250,000 
dilution of DAPI (Invitrogen, #D21490) was added to the second 1X SSC wash (final 
concentration 100ng/mL). Coverslips were then mounted on slides with Prolong Gold 
(Invitrogen P36930).  
 
Immunofluorescence 
For IF experiments, cells were cytospun onto glass slides at 800 rpm for 3 
minutes and then fixed in 4% paraformaldehyde for 10 minutes. Fixed slides were 
washed with PBS + 0.01% Tween-20 (PBST) and stored in 70% ethanol at -20C until 
use. 
 
Slides were washed twice in PBST for 5 minutes, then blocked in IF blocking 
buffer (PBS + 5% goat serum, 0.2% fish skin gelatin, 0.2% Tween-20) at room 
temperature for 1 hour. Primary antibodies were diluted in blocking buffer and incubated 
on slides at 4C overnight. Primary antibodies used were H3K27me3 (Active Motif 
#39055) and H3Lys4 (Millipore #07-030) at dilutions of 1:300 and 1:500 respectively. 
Slides were washed twice in PBST for 5 minutes, then incubated with secondary 
antibodies diluted in IF blocking buffer. Secondary antibodies used were Alexa488-
conjugated goat anti-rabbit IgG (Jackson 711-545-152), Cy3-conjugated goat anti-rabbit 
IgG (Jackson 715-165-152), and Cy3-conjugated goat anti-mouse IgG (Jackson 715-
165-150) at dilutions of 1:500. Slides were washed three times in PBST for 5 minutes 
with DAPI added to the second wash (final concentration 100ng/mL). Slides were then 
mounted using prolong gold antifade (Molecular Probes P36930) and imaged. 
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RNA-seq library prep  
At each time point, cells were harvested with Accutase (ThermoFisher 
#A1110501), pelleted at 500 g x 5 mins, resuspended in 1 ml Trizol, and snap frozen 
until all samples were harvested. 
 
RNA from all samples was extracted from mESCs using Zymo DirectZol RNA 
miniprep kit. RNA purity and quantification were assayed with Qubit dsDNA HS Assay 
Kit (ThermoFisher Q32854) and 500 ng of RNA per sample was used as input for library 
prep. Libraries were prepared using Lexogen SENSE Total RNA-seq Library Prep Kit. 
 
RNA-seq processing and analysis 
Libraries were sequenced on an Illumina Hiseq 4000 with single-end 50 base 
reads. Reads were aligned to the mouse genome (Ensembl build GRCm38.p6) and 
gene counts were created using STAR_2.5.3a. Normalization and differential 
expression analysis was performed with DESeq2v1.20.0.  TPMs were generated with 
Kallisto v0.45.0 and transcript TPMs were collapsed into gene TPMs using a custom 
script. 
Linear regression to determine slope of change in expression over time was 
performed with scikitlearn. For each sample, the slope was normalized to baseline 
expression of that gene at Day 0. This prevents genes that are simply more highly 
expression from exhibiting more variance and therefore artificially steeper slopes and 
allows us to compare slopes between genes of different levels of baseline expression.  
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All data was visualized using Matplotlib and seaborn. 
 
10X library prep, sequencing and analysis 
Stem cells (Day 0 mESCs, Day 2 EpiLCs, and Day 4 EpiLCs) were harvested 
with Accutase (ThermoFisher #A1110501) and resuspended at a concentration of 1200 
cells /uL 1X PBS with ~ 0.05% FBS. Samples were multiplexed using MULTI-seq 
labelling and pooling, as described (McGinnis et al. 2019). 
Libraries were prepared with chromium single cell 3’ reagent kit (v2 chemistry) 
and were sequenced on an Illumina Hiseq 4000 with paired end 28 bp x 98 bp reads. 
Data analysis was performed with CellRanger and Scanpy. 
 
Statistical tests 
A non-parametric Kolmogorov-Smirnov (KS) test was performed to test whether 
CDFs of X-linked genes vs autosomes was significantly shifted downwards. In order to 
only consider genes that were expressed during the ESC to epiLC differentiation, a 
global cutoff of average TPM > 1 was applied to all samples. 
 
Results 
 
Xist homozygous mutant ESCs exhibit normal differentiation 
In order to ask whether Xist is necessary during the initial establishment of XCI, 
we first generated mESCs that lack functional Xist. The A repeat is a highly conserved 
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domain which lies within exon one of Xist that is necessary for proper splicing and 
function of the transcript (Royce-Tolland et al. 2010). We disrupted the A repeat in one 
or both copies by replacing it with an antibiotic resistance marker. First, we generated 
heterozygous Xist mutant mESCs by replacing one copy of the A repeat with a 
neomycin resistance cassette. Next, we generated homozygous Xist mutants by 
replacing the other copy of the A repeat with a hygromycin resistance cassette. In both 
cases, the antibiotic resistance marker was transcriptionally controlled by Xist’s 
antisense transcript, Tsix, and allowed for us to select for cells that maintained two X 
chromosomes (figure 2.1.a). We isolated independently derived clones of the 
heterozygous and homozygous Xist mutants to serve as biological replicates for this 
study. In addition, we introduced a 2A-GFP into the endogenous Rex1 locus into every 
line (figure 2.1.b). Rex1 is a pluripotency transcription factor that is quickly 
downregulated when mESCs are differentiated into epiblast-like cells (epiLCs), which 
recapitulates the random XCI that occurs during the transition of the inner cell mass to 
epiblast.  
We observed that the heterozygous and homozygous Xist mutant mESCs 
appeared morphologically similar to their wild type (WT) counterparts (figure 2.1.c). We 
queried whether the mutant cell lines maintained two X chromosomes by RNA FISH for 
a gene that escapes XCI, Kdm6a, and found that all three genotypes maintained 
biallelic expression (figure 2.1.d).  
To determine the appropriate window in which to study the Xist homozygous 
mutant ESCs, we first compared the kinetics of Rex1-2A-GFP silencing and Xist up 
regulation in WT cells. We performed an epiLC differentiation time course and 
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measured the percentage of GFP positive cells.  In parallel we performed an Xist RNA 
FISH time course, quantifying the percentage of cells that exhibited Xist clouds at each 
time point. We found an inverse relationship between Xist upregulation and Rex1-GFP 
downregulation, with the majority of cells having silenced Rex1-GFP and activated Xist 
by Day 4 (figure 2.1.e). We next examined whether heterozygous or homozygous 
mutation of Xist affected silencing of Rex1-GFP and found that the kinetics of silencing 
were comparable between all three genotypes (figure 2.1.f). Xist homozygous mutant 
mESCs exhibited no Xist upregulation by RNA FISH. Wild type, heterozygous Xist 
mutant, and homozygous Xist mutant mESCs appeared morphologically similar to each 
other at the beginning and end of the time course, with GFP images reflecting GFP 
percentages obtained by FACS (figure 2.1.g). These results suggest that mutation of 
Xist does not impair differentiation into epiLCs.  
  
 19 
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RNA-seq reveals large similarities between kinetics of X-linked gene expression 
To determine the effects of Xist deletion on global gene expression during the 
ESC to epiLC transition, we performed RNA-seq on the three genotypes of mESCs 
(wild type, two clones of heterozygous Xist mutant mESCs, three clones of homozygous 
Xist mutant mESCs) at four time points of epiLC differentiation: Day 0 (undifferentiated), 
Day 3, Day 4, and Day 5(figure 2.2.a). Normalized expression of transcripts (TPMs) was 
calculated for each sample.  
First, we queried a panel of epiblast specific differentiation genes, including Fgf5, 
and T and observed a sharp increase in expression between Day 0 and Day 5 in all 
genotypes (figure 2.2.b). We then queried a panel of pluripotency genes, including 
Nanog, and Sox2, and found a steep decrease in expression between Day 0 and Day 5 
in all genotypes (figure 2.2.b). Xist expression increased sharply over time in the 
wildtype and heterozygous mutants, but not in the homozygous mutants, as expected 
(figure 2.2.c). These results provide additional data suggesting heterozygous or 
homozygous mutation of Xist does not dramatically impair differentiation into epiLCs.  
To ask how the global gene expression of each genotype changed over the time 
course, we performed PCA analysis on the transcriptomes of all samples. This revealed 
that all genotypes follow similar trajectories through PC space between Day 0 and Day 
4 (figure 2.2.d), suggesting that Xist mutants behave similarly to wild type cells during 
early differentiation. Between Day 4 and Day 5, two of the three Xist homozygous 
mutant clones appear to behave differently in PC space when compared to the wild type 
and heterozygous mutant trajectories.  
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Next, in order to query whether our epiLCs were dosage compensating, we 
looked at the fold change in expression of all X-linked genes. Cumulative distribution 
plots of fold changes (Day 0 TPM/Day 5 TPM) from RNA-seq revealed statistically 
significant rightward shift for X-linked genes relative to autosomal genes in all three 
genotypes (K-S test, p < 0.05) (figure 2.2.e, left column). Since all samples experienced 
the same global cutoff for expression (see methods), the number of genes queried in 
each CDF is the same, and therefore the p-value reflects the intensity of the shift, with 
the Xist homozygous mutant shift (p = 1.5e-06) slightly less than the wild type (p = 2.3e-
09) or Xist heterozygous mutant shift (p = 3.8e-13). This shift was not observed when 
comparing autosomes, such as chromosome 11 which is of similar gene density to 
chromosome X, to the rest of the autosomes (p = 0.19) (figure 2.2.e, right column). 
Together these results suggest that Xist homozygous mutants are capable of dosage 
compensating genes on the X chromosome, albeit to a smaller degree than their wild 
type counterparts. This shift could be due to two possible reasons: 1) all X-linked genes 
are partially dampened in their expression or 2) some X-linked genes are silenced while 
others aren’t.  
To address the second possibility, we sought to capture and compare the 
kinetics of all ~800 appreciably expressed X-linked genes during the epiLC 
differentiation time course. We applied linear regression to TPMs of each gene over 
time, followed by normalization of the slopes to allow for comparison between genes 
(see methods). This regression revealed three archetypes of kinetics (figure 2.2.f). 
Some genes, such as Prps1, decreased in expression very sharply (m < - 0.1). Some 
genes, such as Hprt, decreased in expression slowly (m < 0), and some genes, such as 
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Huwe1, exhibited a noisy or slight increase in expression (m > 0). In order to holistically 
compare the kinetics of all X-linked genes between genotypes, we performed 
hierarchical clustering on the slopes (figure 2.2.g). Most clusters of X-linked genes that 
exhibited similar slopes held across all genotypes. However, this clustering revealed a 
subset of X-linked genes that exhibited differences in slope between Xist homozygous 
mutants and genotypes containing at least one functional copy of Xist. Performing GO 
term analysis on this subset of genes revealed a statistically significant (p value here) 
enrichment for genes involved in sister chromatid cohesion. This clustering also 
revealed, as expected, closest taxonomic relationships were between independently 
derived clones each genotype, reinforcing the robustness of this phenotype. Together 
this data suggests that some X-linked genes decrease in expression in the absence of 
Xist, while other X-linked genes do not. 
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Single cell RNA-seq reveals similar differentiation trajectories between wild type 
and Xist homozygous mutant ESCs  
RNA-seq on a bulk population of cells gives the average expression of a 
particular transcript. Since we are querying differentiation, a process known to be 
heterogeneous, bulk transcriptomic methods can blur out the signals of interest - in this 
case, the initiation of X chromosome inactivation. To obtain a higher resolution picture 
of how a population of cells moves through the differentiation, applying single cell RNA-
seq allows us to identify cells that are actively differentiating and then restrict our 
analyses to just those subsets. 
We performed single cell RNA-seq at multiple time points of epiLC differentiation 
using the 10X platform in conjunction with MULTI-seq to label and pool samples 
(McGinnis et al. 2019). Wildtype and Xist homozygous mutant cells (KO) were 
harvested at Day 0 (undifferentiated), Day 2, and Day 4 of epiLC differentiation for 
single cell RNA-seq. Transcriptomes for each cell were projected into low dimensional 
space using UMAP dimensionality reduction (figure 2.3.a). We qualitatively observed 
grouping of cells strongly correlated with each time point, and labelled these “pre-
differentiation”, “mid-differentiation” and “late-differentiation” clusters (figure 2.3b). To 
confirm that these clusters reflected each time point, we applied an unbiased clustering 
algorithm (leiden) to look for similar groupings (figure 2.3c). Wildtype and Xist mutant 
genotypes showed similar occupancies between clusters (figure 2.3.d). We observed 
cluster and subclusters that strongly corresponded to the time point of the sample, for 
both genotypes. Defined clusters corresponding to pre-differentiation, mid-
differentiation, and late-differentiation were consistent with upregulated or 
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downregulated expression of key differentiation and pluripotency markers (figure 2.3.e-
f). Of the cells within a defined cluster, the distribution of expression of key markers 
(Rex1, Fgf5) of interest were qualitatively similar between genotypes (figure 2.3.e, 
2.3.g). This suggests that wild type and Xist homozygous mutant cells have similar 
trajectories through epiLC differentiation, consistent with bulk RNA-seq and Rex1-GFP 
expression demonstrating that Xist homozygous mutant cells differentiate without 
apparent defect. Trends in the distribution of an X-linked gene’s expression (Renbp) 
were also similar between wild type and Xist homozygous mutants (figure 2.3.f), 
suggesting that loss of Xist does not dramatically affect the behavior of X-linked genes. 
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RNA FISH for a panel of X-linked genes shows variability in silencing between 
genotypes  
Our bulk and single-cell RNA-seq data suggested that a significant number of X-
linked genes exhibited similar differentiation-induced changes in expression in wild-type, 
heterozygous, and homozygous Xist mutants. These data suggest that down regulation 
of some X-linked genes occurs in the absence of Xist. To examine whether this down 
regulation occurs due to reduced expression on one or both Xs, we employed RNA 
FISH to detect nascent transcripts from X-linked genes.  
We chose genes that were appreciably expressed during this developmental 
window, and that varied in their location along the X (fig 4a). In each RNA FISH 
performed, the X-linked gene of interests was paired with Kdm6a, an XCI escapee. Only 
cells with two pinpoints of expression for Kdm6a were considered. Percent monoallelic 
(one spot) vs percent biallelic (two spots) calculations for each X-linked gene revealed 
three archetypes (fig 4b). Some genes showed mostly biallelic expression in the Xist 
homozygous mutants, despite considerable monoallelic expression in the wild type and 
heterozygous mutants. Some genes showed a lower number of cells with monoallelic 
expression in the Xist homozygous mutants, when compared with the wild type and 
heterozygous counterparts. Some genes exhibited equal levels of monoallelic 
expression between all three genotypes. These results suggest there is heterogeneity in 
whether or not a particular X-linked gene can silence without Xist. 
 
 28 
 
Figure 2.4. FISH for X-linked genes reveals three archetypes. A) Location of X-linked genes 
probed with RNA FISH. B) Some genes (left) showed silencing off one X in the mutants, some 
genes (center) failed to show monoallelic expression in Xist homozygous mutants, and some 
genes (right) showed a lower percentage of monoallelic expression in the Xist homozygous 
mutants. 
 
Discussion 
X chromosome inactivation is a process essential for life. While Xist is a key 
regulator, potential compensatory mechanisms for this crucial process may exist. To 
uncover potential Xist independent silencing mechanisms, it is important to identify 
whether Xist is necessary for the establishment of X chromosome inactivation in the first 
place. While work by Lee et al. suggest female mice lacking Xist can dosage 
compensate, the experiments performed do not investigate the initial establishment of X 
inactivation. Since it is difficult to time the delivery of Cre recombinase during the 
precise developmental window of X inactivation in the inner cell mass, we cannot say 
for sure that cells lacked Xist during the moment X inactivation was initially established. 
Additionally, by querying tissues from the pups that survived gestation, by definition, 
only cells that did not require Xist to survive are observed. qPCR for Xist in these 
tissues show varying levels of expression, which might suggest low levels of persistent 
Xist expression can rescue an otherwise inviable cell. 
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Homozygous Xist mutant ESCs show silencing of X-linked genes 
The dynamics of what happens to X-linked gene expression at the moment when 
a female cell lacking Xist attempts to initiate silencing is not well studied or 
understood. In this study, we investigate the establishment of X chromosome 
inactivation in the absence of Xist using mESCs as a tractable ex vivo model. We 
induce X chromosome inactivation by differentiating mESCs lacking functional Xist into 
epiblast-like cells. 
Two classes of X-linked genes? 
Although some genes on the X chromosome appear to be silenced, some genes 
appear to be Xist-dependent in their silencing. Our data suggest that there are two 
classes of genes, ones that can be silenced without Xist and genes that require this 
non-coding RNA for robust silencing. 
Our FISH results give a clear readout of monoallelic vs biallelic nascent 
expression in our mutants, and some genes exhibit monoallelic silencing better than 
others. This result is consistent with the work by Schulz et al. demonstrating that Huwe1 
is not silenced in Xist-null mESCs. One possible explanation for our result is that some 
sections of the X chromosome are silenced, while other sections are dampened in 
expression, explaining the two classes of X-linked gene silencing observed. FISH for 
more loci along the X chromosome, along with allele-specific RNA-seq would help with 
this discrepancy. Additionally, performing these experiments in a cell line with a genetic 
background that allows for allele specific information on RNA transcripts would help 
distinguish, chromosome-wide, whether the Xist homozygous mutants are dampening 
their expression from both X chromosomes, or silencing one X chromosome. 
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Of the ~800 appreciably expressed X-linked genes, we observed variability in 
reduction of expression, even in wild type. All X-linked genes do not cleanly decrease 
their RNA transcripts by half. Since we are querying the steady state levels of RNA in 
the cell at each time point, transcripts that have not yet been degraded may also be 
captured. Performing NET-seq to only capture nascent RNA transcripts may better 
reflect changes in transcription during differentiation. However, ex vivo differentiation 
methods take place more gradually than X inactivation in vivo - on the order of days 
instead of hours. Since the typical half-life of RNA in mESCs is ~8 hours, performing 
NET-seq may not have an appreciable effect. 
A reason to investigate 3D structure 
Our results hint that genes involved in sister chromatid cohesion are 
dysregulated in our Xist homozygous mutants. Perhaps the Xist-dependent 
downregulation of cohesion proteins plays a role in the changes in 3D organization of 
the X chromosome that occurs during silencing. Performing Hi-C or 3C in WT cells and 
our mutant cells would be reveal any differences in 3D structure.   
Our work joins the body of literature suggesting that Xist-independent 
mechanisms for silencing exist (Kalantry et al. 2009, Namekawa et al. 2010). Our study 
investigates, for the first time, the onset of X inactivation in mESCs lacking Xist at single 
cell transcriptomic resolution. Xist homozygous mutants appear to differentiate and 
silence some X-linked genes as well as wildtype. Perhaps other regulatory ncRNAs in 
the vicinity are compensating for lack of Xist to help silence some genes. Further work, 
such as a functional genomic screen for key regulators, will be necessary to uncover the 
molecular underpinnings of an Xist-independent dosage compensation mechanism. 
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Table 2.1. List of BACs used for FISH probes. 
 
Gene Probe ID 
Kdm6a RP23-56E7 
Lamp2 RP24-173A8 
Renbp RP24-339B4 
Dynlt3 RP23-406F22 
Chic1 RP24-293G24 
Prps1 RP24-255A11 
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Chapter three 
 
Deletion and analysis of the X inactivation center in male and 
female mESCs 
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Introduction 
In order to balance X-linked gene dosage between XX females and XY males, 
female mammals silence one X chromosome in each cell early during embryogenesis. 
In eutherian embryos, X-inactivation is random in that each X chromosome has an 
equal probability of being inactivated (Lyon et al. 1961). 
Analysis of deletions and translocations involving the X chromosome indicates 
that a 1-2 Mb region, termed the X-inactivation center (Xic), is important for counting, 
choice, and establishment of XCI (Augui et al. 2011). The Xic is necessary in two copies 
for XCI to occur, indicating it is necessary for counting. In mice, this ~2 Mb region 
contains protein coding genes, pseudogenes, and regulatory noncoding RNAs, 
including Xist and Tsix (Morey et al. 2001). 
Xist is up regulated exclusively in female cells. This up regulation requires 2 
copies of the Xic, which includes Xist: when the Xic is missing one X chromosome, Xist 
is not up regulated the other wild type X. This observation raises the question of what is 
encoded in the Xic that allows female cells to be competent to up regulate Xist. To 
begin to understand what kind of regulatory elements lie within the Xic, the minimal Xic 
must be identified. Translocations and truncations in mice have identified a 1-2Mb 
region necessary for Xic function (Brown et al. 1991), but more focused deletion 
analysis has not been reported.  
Previous studies have attempted to narrow down the Xic using transgenes 
encoding portions of the 1-2 Mb region, centered on Xist. One study inserted a 450 kb 
transgene, which included the sequences surrounding Xist, in multiple copies at various 
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autosomal sites in XY ESCs (Lee et al. 1996). In some integration sites these multi-copy 
transgenes triggered up regulation of Xist from the single X chromosome, albeit in a 
small proportion of cells. Similar results have been obtained with a multi-copy insertion 
of 35 kb transgene corresponding to 9 kb upstream and 6 kb downstream of Xist 
(Brockdorff et al. 1998).  
While these results suggest that crucial cis-regulatory elements lie within the 
450kb or the 35 kb regions, several lines of evidence suggest that this transgenic 
analysis has not identified the elements necessary for correct up regulation of Xist. First, 
deletion of the 35kb region from one X chromosome in female ESCs does not perturb 
Xist up regulation on the wild type. Thus, this region does not contain the information 
that is crucial for making cells competent to count X chromosomes and up regulate Xist. 
In addition, while a small number of differentiating multi-copy transgenic ESCs up 
regulate Xist from the endogenous X chromosome, none of these transgene studies 
report endogenous Xist up regulation with a single copy insertion. Together these 
results indicate that the crucial Xic elements reside outside of the region encompassed 
by the 35kb transgene and that inserting large multi-copy transgenes which encompass 
Xist may not reflect the actual biology behind counting endogenous X chromosomes.  
We sought to pursue a more biologically informative approach to identify the 
minimal Xic sequences. We aimed to use CRISPR-Cas9 genome editing (Lin et al. 
2014) to systematically delete regions of the 1-2 Mb Xic in female mESCs and then 
query for Xist up regulation on the wild type X chromosome.  
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Materials and methods 
 
Cell culture 
The mESC line LF2, E14, and its derivatives were routinely passaged by 
standard methods in KO-DMEM, 10% FBS, 2 mM glutamine, 1X non-essential amino 
acids, 0.1 mM b-mercaptoethanol and recombinant leukemia inhibitory factor. The 
mESC line 2-1 was routinely passaged in the same way, but on top of a layer of 
irradiated MEFs at a density of one vial (1E6 cells) per 10 cm^2, per passage. 
Generation of mutant mouse embryonic stem cell lines 
mESC lines were derived using CRISPR-Cas9 genome editing. A guide RNA to 
the Rlim or OGT’s UTR region was cloned into the px459-Cas9-2A-Puro plasmid using 
published protocols (Ran et al., 2013). Templates for homology directed repair were 
amplified from Gene Blocks (IDT) (Tables S1 and S2). Plasmid and template were co-
transfected into mESCs using FuGENE HD (Promega) according to manufacturer's 
protocol. After two days cells were selected with puromycin for 48 hours, then allowed 
to grow in antibiotic-free media. For fluorescent constructs, cells were monitored for 
fluorescence (indicating homology directed repair) and fluorescent cells were isolated 
by FACS 1-2 weeks after transfection. To transfect mESCs with Cre recombinase 
protein, Cre Recombinase Gesicles (Clontech #631449) were added to culture 
according to manufacturer’s protocol. For blasticidin selection, cells were monitored for 
antibiotic resistance and single cell clones were picked and expanded. Subclones were 
generated by sorting for single cells with FACS on a BDAriaII machine. All cell lines 
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were propagated from single cells and correct insertion was confirmed by PCR 
genotyping. 
FISH 
Cells were harvested, resuspended to 500,000 cells/ml, and then cytospun onto 
glass slides at 800 rpm for 3 minutes. Cells were then permeabilized through sequential 
treatment with ice-cold cytoskeletal extraction buffer (CSK:100 mM NaCl, 300 mM 
sucrose, 3 mM MgCl2, and 10 mM PIPES buffer, pH 6. 8) for 30 sec, ice-cold CSK 
buffer containing 0.4% Triton X-100 (Fisher Scientific, #EP151) for 30 sec, followed 
twice with ice-cold CSK for 30 sec each. Finally, cells were then fixed in 4% 
paraformaldehyde for 10 minutes and stored at -20C in 70% ethanol until use. 
The dsRNA FISH probes were made by randomly priming DNA templates using 
BioPrime DNA Labeling System (Invitrogen, #18094011). Probes were labeled with 
Fluorescein-12-dUTP or -UTP (Invitrogen) or Cy3-dCTP or –CTP (GE Healthcare). 
Probes were stored at -80C until use. 
Slides were dehydrated through 5 min incubations in 80%, 90%, and 100% 
ethanol solutions and air-dried. 2ul of probe was hybridized overnight on the slides in a 
humid chamber at 37C. The samples were then washed 3X for 5 min at 39C with 
2XSSC/50% formamide, 3X for 5 min SSC, and 3X for 5 min with 1X SSC. A 1:250,000 
dilution of DAPI (Invitrogen, #D21490) was added to the second 1X SSC wash (final 
concentration 100ng/mL). Coverslips were then mounted on slides with Prolong Gold 
(Invitrogen P36930).  
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Results 
 
HDR mediated recombination rates are very low in female mESCs 
Our starting female cell line contains one X chromosome from a 129 mouse 
background, and the other X chromosome from a Castaneus mouse background. As a 
result, there is a SNP approximately every 120 base pairs between these two X 
chromosomes. In order to specifically target Cas9 to the 129 allele that contains the 
existing loxP site, we designed our guide RNA sequences to include SNPs unique to 
the 129 X chromosome in the crucial protospacer adjacent motif (PAM) site of the guide 
RNA. While SNPs in the guide RNA sequence itself can be tolerated and still cleaved at 
a lower frequency by Cas9, mismatches in the PAM site are not recognized and 
therefore should not be cleaved (Barrangou et al 2007). 
We first chose to target the centromeric end of the Xic, and designed guide 
RNAs for within Rlim, a protein coding gene that is the rough boundary of the 
centromeric end of the Xic. We first chose to use short single stranded donor 
oligonucleotides (ssODNs) as donor DNA for homology directed repair (HDR) of the 
Cas9-induced cleavage site. Previous CRISPR method studies had demonstrated short 
arms of homology were sufficient to serve as templates for HDR in HEK293T cells (Lin 
et al. 2014).  Our ssODN was 200 bp and contained just a loxP site surrounded by 
homologous sequence to our cleavage site. 
We electroporated the 2-1 female mESCs with Cas9, sgRNA, and ssODN. We 
grew up several 96 well plates of single cell clones from the electroporation, and then 
used PCR genotyping on the genomic DNA to determine which single cell clones had 
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our small loxP insertion. Assuming we achieved HDR in only one allele, a PCR product 
spanning the targeted region should show two bands: one band for the wild type allele, 
and a slightly larger band for the allele that had successful integration of the loxP. 
Unfortunately, after several electroporation attempts, we were unable to isolate a single 
cell clone with integration of our ssODN near our target site, Rlim. 
Engineering a strategy to enrich for desired targeting events 
We sought to redesign our targeting strategy to be improved in two ways: 1) 
using fluorescent reporters to enrich for successful HDR and integration of a loxP site 
and 2) an antibiotic resistance marker to select for cells that successfully excised the 
region between the two loxP sites (figure 3.1).  
 
 
Figure 3.1. Improved strategy for deleting the Xic. Our original strategy (left) relied 
on screening clones by PCR to select for cells that had our desired loxP (black triangle) 
insertion. Our revised strategy (right) uses fluorescent reporters and antibiotic 
resistance to enrich and select for cells with the Xic deletion. 
 
In order to enrich for cells that have our desired loxP site insertion, we chose to 
attach the loxP site to a fluorescent reporter. By pairing the loxP with a 2A-tdTomato or 
2A-GFP construct, we could then sort for red or green cells. This strategy required us to 
target protein coding genes that are appreciably expressed in mESCs. We chose to 
target Rlim as a centromeric boundary and OGT as a telomeric boundary for the Xic, 
because both genes are expressed highly enough to visualize GFP or tdTomato. At this 
OGT – 2A – GFP – PGK 
Blast – tdTomato – 2A – Rlim  (2 MB)
+ Cre
OGT – 2A – GFP – PGK     Blast 
tdTomato – 2A – Rlim  
(2 MB)
+ Cre
(-Xic) (-Xic)
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time we also chose to use a different female mESC line, LF2, because 1) LF2s don’t 
require feeder cells and 2) LF2s anecdotally maintain two X chromosomes better than 
the 2-1 cell line during culture. 
Next, in order to select for cells that successfully recombined out the Xic between 
the two loxP sites, we chose to separate a promoter from the coding region of an 
antibiotic resistant marker, blasticidin. This way, only when the two distant loxP sites 
come together and recombine out the Xic, will the cell successfully transcribe blasticidin 
resistance. This engineering is necessary, because the further away two loxP sites are, 
the less efficient Cre-mediated recombination is. Previous studies have tested the limits 
of this system and shown that 75% of chromosome 11 could be deleted, albeit with very 
low efficiency (Zheng et al. 2000). 
To generate this cell line, we first generated the OGT-2A-GFP-PGK-loxP cell line 
by sorting for GFP positive cells post transfection, followed by PCR genotyping and 
Sanger sequencing to confirm the introduction of our PGK promoter and loxP site. Next 
we targeted Rlim and inserted the 2A-tdTomato-Blast-loxP cassette, following similar 
methods.  
Cis or trans? Deleting the sole Xic in male cells provides a critical control 
We successfully generated a female cell line with two loxP sites on the rough 
boundaries of the putative mouse Xic. However, we still did not know the orientation of 
the two loxP sites. In order to delete one copy of the Xic, we needed to have the loxP 
sites in cis, on the same X chromosome. If the loxP sites were in trans, then Cre-
mediated recombination would result in two copies of the Xic on one X chromosome, 
with no copies on the other (Figure 3.2).  
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Figure 3.2. Targeting can result in loxP sites in either a cis or trans orientation. 
Since female cells have two copies of the X chromosome, it was important to consider 
the outcome of our targeting events. In order to successfully delete one copy of the Xic, 
loxP sites must be in cis on one X chromosome (top). If loxP sites are in trans (bottom), 
then we will be unable to excise the Xic upon the introduction of Cre recombinase. 
 
As a control, we chose to generate a male mESC line that had the same 
insertions at OGT and Rlim to allow for Cre-mediated recombination. Since male cells 
only have on X chromosome, the orientation of the loxP sites are guaranteed to be in 
cis, allowing for us to test our Cre in a controlled system. We introduced Cre to our male 
mESCs with two loxP sites, and then selected with blasticidin to only allow cells that had 
successfully recombined out the Xic to survive. 
To test for successful recombination, we designed a set of primers that would 
give a band only if the surrounding sequences of the two loxP sites were recombined to 
be close to each other. We ordered a synthesized block of DNA as a positive control for 
this PCR reaction. PCR genotyping demonstrated successful deletion of the Xic in male 
mESCs (Figure 3.3a). However, Sanger sequencing of this PCR product revealed a 
small (40 bp) deletion in the expected sequence (Figure 3.3b). This small deletion, with 
a slight variant in length and location, was observed in an independent Cre 
OGT – 2A – GFP – PGK 
Blast – tdTomato – 2A – Rlim  
(2 MB)
OGT
Rlim
(2 MB)
XaXa-Xic
+ CreLoxP in Cis
OGT – 2A – GFP – PGK 
Rlim
(2 MB)
OGT
Blast – tdTomato – 2A – Rlim  
(2 MB)
+ CreLoxP in Trans
Xa-XicXaXic (2)
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recombination experiment. This deletion was not present in the plasmids used in the 
transfection, suggesting the cells themselves created this small deletion post 
transfection. 
 
Figure 3.3. Evidence of Xic deletion in male cells. A) PCR genotyping confirms 
deletion of the sole Xic in male (E14) cells. Expected band size = 823 bp. B) Sanger 
sequencing of the PCR product shown in panel A reveals a small deletion in the PGK 
promoter which drives blasticidin resistance. 
 
Deleting one copy of the Xic in female mESCs results in genomic instability 
Next we took the female cells, which theoretically have a mixture of the two loxP 
sites in cis and in trans, and transfected in Cre followed by blasticidin selection for cells 
that had successful recombination. When we performed PCR genotyping to confirm the 
recombination, we got a mixture of positive and negative results on our single cell 
clones, suggesting some of the isolated clones did not have the deletion, despite 
blasticidin treatment (Figure 3.4a). In order to more robustly generate single cell clones, 
we then transfected with Cre, followed by single cell plating in a 96-well plate using 
FACS and very stringent gating. Once those single cells recovered, we then treated with 
blasticidin.  
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We continued to follow up on the clones that demonstrated an Xic deletion by 
PCR genotyping by sanger sequencing the PCR product. Again we observed the same 
small mutation in the PGK promoter, in a slightly different placement than the male 
cells, supporting the suggestion that this mutation is generated from selective pressure 
(Figure 3.4b) 
 
Figure 3.4. Evidence of Xic deletion in female cells. A) PCR genotyping confirms 
deletion of the Xic in female cells. Expected band size = 823 bp. B) Similar to male 
cells, sanger sequencing of the deletion PCR product reveals a small deletion in the 
PGK promoter which drives blasticidin resistance. 
 
To test if our female clones were truly missing one copy of the Xic, we performed 
we performed fluorescent in situ hybridization (FISH) for nascent RNA transcripts for 
Xist. Instead of observing one pinpoint of nascent expression, the clones largely 
demonstrated two pinpoints of expression for Kdm6a, suggesting the cell line still 
contained two copies of the Xic. One subclone had one pinpoint of expression for Xist, 
but also had one pinpoint of expression for Atrx, a X-linked gene outside of the Xic, 
suggesting that subclone had lost an X chromosome in culturing (Figure 3.5). 
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Figure 3.5. Female Xic delete subclones. A) PCR genotyping showing variability in 
Xic deletion band between subclonal populations. B) FISH showing one pinpoint of X-
linked gene expression in subclone 2-2, indicating the cell line had lost an X 
chromosome. 
 
To ensure that this was not due to heterogeneity in the population of wild type 
and Xic delete cells, we performed a second round of blasticidin selection and 
subcloned the population into 96-well plates by FACS. Reperforming PCR genotyping 
on the subclones revealed the loss of the PCR product that signified the Xic had been 
deleted. RNA FISH on these subclones also showed two pinpoints of Xist expression, 
suggested that the subclones were likely wild type cells not harboring the Xic deletion. 
Several rounds of reperforming the cre-recombination, followed by blasticidin resistance 
and subcloning gave the same result. We could transiently observe the deletion PCR 
product, and even sanger sequence it, but we were unable to get a pure, stable 
population of mESCs lacking the Xic. 
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Discussion 
In summary, we deleted the X inactivation center, a genetic element shown to be 
necessary in two copies for female cells to count, in both male and female cells. Our 
engineering of the cell lines cleverly allowed for enrichment and selection of our 
genotype of interest, saving valuable time and reagents required for screening many 
plates of clones. However, we were unable to obtain a stable, pure population of female 
cells that lacked the Xic. 
With additional time and resources, it is possible that a smaller deletion of the Xic 
could be better tolerated. However, the current design capitalizes on the use of 
promoters from expressed transcripts as a means of also expressing selectable 
fluorescent markers. The putative Xic has a limited number of transcripts that are 
expressed highly enough to be compatible with this strategy. One possible way to 
overcome this is to insert fluorescent markers with their own promoters, but this comes 
with the cost of random, off target integrations causing false positive fluorescent cells. 
Another obstacle to overcome is the starting orientation of the loxP sites. In male 
cells, this is not an issue, as the loxP sites will always be in cis. In female cells, it 
becomes critical that cells have the loxP sites in the right orientation prior to transfection 
with Cre. To overcome this in the future, starting with a cell line that allows allele 
specific CRISPR targeting is necessary. 
With these obstacles in mind, it is important to remember that these edits are 
performed in live cells that may then produce their own, unexpected, compensatory 
mutations. A clear example of this was the small deletion in the PGK promoter that was 
observed in independent experiments. This was unexpected and therefore difficult to 
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plan for, and necessitates the need to checkpoints along the way, perhaps through a 
combination of sanger sequencing and whole genome sequencing, to ensure the 
genome has not undergone unexpected rearrangements. 
Ultimately, stable deletion of the Xic in female cells would allow for exciting follow 
up experiments. First, we would differentiate the mESCs in various ways to observe 
whether or not X chromosome inactivation is adversely affected. Epiblast-like cell 
differentiation, as described in chapter two, is a straightforward way to do this. 
Additionally, we could inject the Xic delete mESCs into mouse blastocysts and grow 
them out ex vivo to see if they undergo X inactivation during early development. 
Experiments to query X inactivation include RNA FISH for Xist, and 
immunofluorescence for markers of the inactive X such as H3K27me3 and macroH2A 
enrichment (Brinkman et al. 2006, Changolkar et al. 2006). If deleting the entire Xic had 
an adverse effect, then we would create successively smaller and smaller deletions to 
map the minimal element needed in two copies.  Identification of minimal element 
necessary in two copies for Xist up regulation is a key first step in understanding the 
molecular framework that allow ESCs to count their X chromosomes. It would be a 
groundbreaking step in determining a mechanism for this poorly understood process. 
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Chapter Four 
 
Activators and repressors: A balancing act for X-inactivation 
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Abstract  
In early female embryos X-chromosome inactivation occurs concomitant with up 
regulation of the noncoding RNA, Xist, on the future inactive X-chromosome. Up 
regulation of Xist and coating of the future inactive X is sufficient to induce silencing. 
Therefore, unlocking the mechanisms of X-chromosome inactivation requires thorough 
understanding of the transcriptional regulators, both activators and repressors, which 
control Xist. Mouse pluripotent embryonic stem cells, which have two active X 
chromosomes, provide a tractable ex vivo model system for studying X-chromosome 
inactivation, since this process is triggered by differentiation signals in these cultured 
cells. Yet there are significant discrepancies found between ex vivo analyses in mouse 
embryonic stem cells and in vivo studies of early embryos. In this review we elaborate 
on potential models of how Xist is up regulated on a single X chromosome in female 
cells and how ex vivo and in vivo analyses enlighten our understanding of the activators 
and repressors that control this non-coding RNA gene. 
 
Introduction 
The central question in X chromosome inactivation (XCI) is: how do cells with two 
X chromosomes (Xs) silence only one of their Xs in the correct developmental fashion? 
In rodent extraembryonic tissues, only the paternally inherited X is silenced (West et al. 
1977, West et al. 1978), a process termed imprinted XCI. In the embryo proper of 
rodents and of other placental mammals XCI is random, and the X inherited from either 
parent may be silenced (Lyon 1961). Because XCI is random in embryonic tissues, 
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there is an additional level of complexity-machinery that allows cells to randomly select 
one X for silencing is integrated into this system. In this review we will describe general 
models for how XX cells can achieve random silencing of one X, and discuss factors 
implicated in this process, focusing findings from the mouse system. X chromosome 
silencing can be divided into two stages (Avner et al. 2001). Establishment of silencing 
occurs first, when one X transitions from the active to the inactive state. Once silencing 
is established, the silenced X is stably maintained throughout all subsequent cell 
divisions. A key player in XCI is the X-linked gene Xist, which encodes a non-coding 
RNA that coats the inactive X (Xi) in cis (Brown et al. 1992). Xist is up regulated on the 
X that will be silenced concomitant with the initial establishment of silencing and 
continues to coat the Xi during the maintenance of silencing. In addition, Xist is 
sufficient to silence a cis-linked chromosome (X or autosome) during a brief 
developmental window (Wutz et al. 2000), consistent with a key role in establishment of 
silencing. Thus, the developmental cues that trigger silencing and the mechanisms that 
allow random choice of one X for silencing all converge on Xist. Identifying the factors 
that promote Xist up regulation on the future inactive X is pivotal to understanding the 
control of XCI. 
 
Developmental control of XCI 
Xist up regulation during random XCI is developmentally controlled (Mak et al. 
2004, Okamoto et al. 2004) In the mouse model, activation of Xist expression occurs 
shortly after implantation (Kay et al. 1993, Sheardown et al. 1997). Prior to implantation, 
the inner cell mass (ICM) of the XX blastocyst, which will give rise to the embryo proper, 
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is composed of cells with two active Xs (Xas). Implantation, which begins at 
approximately embryonic day (E) 4.5, triggers a dramatic reorganization of the ICM. 
Within 24 h, by E5.5, the ICM cells convert to the epiblast, a change to a 
pseudostratified epithelium accompanied by Xist up regulation and establishment of 
silencing (Sheardown et al. 1997).  
A host of dramatic changes occur during implantation (Cha et al. 2015). The exit 
from the glycoprotein shell of the zona pellucida and establishment of contact with the 
uterine membrane is characterized by changes in signaling molecules, extracellular 
matrix contacts, mechanical forces, and oxygen and nutrient availability (Cha et al. 
2015). It remains to be determined whether Xist up regulation is a consequence of one 
or more of these changes. Understanding how developmental signaling pathways 
connect with the transcriptional regulators that control Xist is a key question in XCI.  
While the peri-implantation developmental window is difficult to access in vivo, 
pluripotent stem cells isolated from the ICM provide a model system for the study of XCI 
ex vivo. Pluripotent stem cells resembling cells in the ICM, embryonic stem cells 
(ESCs), can be isolated and propagated ex vivo under appropriate signaling milieus 
(Martello et al. 2014). XX ESCs maintain two Xas, mirroring the cells of the ICM and 
when differentiated in culture Xist is up regulated on the prospective Xi. In vivo a 
complex combination of inputs such as extracellular matrix contacts and nutrient 
availability may intersect with growth factor signaling to direct Xist up regulation. Ex vivo 
analyses may not fully recapitulate the events that control Xist expression. Depending 
on the differentiation method used, Xist up regulation can take several days and is 
generally highly asynchronous in the ESC system. In contrast, the process appears to 
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be synchronous and complete within a 12–24 h window in vivo (Gayen et al. 2015). 
These differences suggest that critical players may be overlooked ex vivo. Factors that 
are not normally important in vivo may play a role under non-physiological ex vivo 
signaling conditions. These concerns highlight the importance of testing the effects of 
candidate regulator mutations in vivo as well as ex vivo. Therefore, whenever possible, 
we will compare and contrast the mutational analysis of potential Xist activators and 
repressors in culture and in embryos 
 
Xist cis-regulatory elements 
In other examples of developmentally controlled up regulation, crucial cis-
regulatory elements exhibit a poised chromatin state before they receive the signal that 
triggers the developmental transition (Bernstein et al 2006, Buecker et al. 2012). This 
poised state is thought to facilitate rapid changes in gene expression in response to 
developmental signaling molecules. In vivo, Xist exhibits rapid up regulation in concert 
with a key developmental transition, suggesting that Xist cis-regulatory elements in ICM 
cells may be in a poised state. 
Consistent with models for poised expression, Xist is transcribed at low levels 
from all Xas in XY or XX ESCs or ICM cells (Beard et al. 1995, Panning et al. 1996). 
This expression is two to three orders of magnitude lower than the level seen after Xist 
up regulation, when Xist RNA coats the Xi. Crucial to understanding Xist expression is 
identification of its cis regulatory elements. In principle a different set of elements may 
direct the low-level expression from Xas in ESCs/ICM, the rapid up regulation of Xist 
expression during establishment of silencing in differentiating cells, and the abundant 
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expression from the Xi during maintenance of silencing in differentiated cells. Chromatin 
capture methods suggest that Xist cis elements in ESCs may lie in an approximately 
500 kb topologically associated domain (TAD) (Nora et al. 2012). It remains to be 
determined whether elements in this TAD play a role in low-level Xist expression in 
ESCs/ICM. In addition, this TAD may contain elements that poise Xist for up regulation 
upon differentiation. While poising is an attractive model for precise developmental 
control of Xist, other models may also explain the rapid and synchronous up regulation 
of Xist on the future Xi upon implantation. 
 
Classes of models 
The observation that individuals with supernumerary Xs silence all but one X, 
lead to the ‘n-1 rule (Lyon 1971). This rule postulates that one X per diploid genome 
remains active, and all additional Xs are silenced (Goto et al. 1998). On the basis of the 
n-1 rule, models postulating that there is a robust system for ensuring only one X 
remains active have been proposed. Models vary on (i) whether the mechanism 
functions before or after Xist up regulation and (ii) whether there is an input from the 
number of Xs. 
 
Models without input from the number of Xs 
One class of model posits that all Xs are competent for Xist up regulation 
regardless of the number of Xs in the cell (Monkhorst et al. 2008) (Figure 4.1). In this 
class of model there are two ways that could ensure that Xist is expressed from only 
one X in XX cells and not at all in XY cells in adult organisms. First, because there is 
 52 
considerable opportunity for selection against incorrectly dosage compensated cells 
throughout development, the cells that survive embryogenesis need not reflect the 
population of cells that initially up regulated Xist in the early post-implantation embryo 
(Takagi et al. 2002). Thus, it is possible that Xist up regulation is not restricted to one X 
in XX cells but may occur more haphazardly. Elimination of incorrectly dosage 
compensated cells in XX and XY embryos would result in XaXi and XaY adults. 
Alternatively, feedback mechanisms can be used to ensure only one allele is expressed, 
as is the case in most other systems of random monoallelic expression (Chess et al. 
2012). In XCI a mechanism that detects incorrect dosage compensation in the 
appropriate developmental window could impact Xist expression to ensure production of 
XaXi or XaY individuals.  
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Figure 4.1. Models in which there is no input from the number of Xs. (a) All Xas (gray bars) 
in XX or XY ESCs/ICM cells (top row) have a small probability of Xist up regulation. As a result 
the epiblast initially consists of cells (middle row) in which neither, one, or both Xs are silenced 
in XX individuals and in which the X in XY individuals in active or inactive (Xi indicated by gray 
circle). Selection or feedback ensures that the final population of cells in the embryo (bottom 
row) consist of one Xa and one Xi in XX animals and one Xa in XY animals. (b) An autosomal 
gene product (red squares) is used to designate the Xa. Binding of this product is highly 
cooperative, such that it can assemble on only one X in XX or XY cells (middle row, left Xs). In 
some cells cooperative binding may not occur on any Xs within the appropriate time window 
(second row, right Xs). Xist is up regulated on the unbound Xs and silencing occurs (third row). 
As in (a), feedback or selection ensures that all somatic cells contain one Xa and one Xi in XX 
animals and one Xa in XY animals. 
 
Consistent with models invoking selection or feedback, Xist up regulation was 
detected on the single X in a small proportion differentiating XY ESCs and on multiple 
Xs in diploid XX and tetraploid XXXX ESCs or tetraploid XXYY ESCs (Monkhorst et al. 
2008). However, these patterns of Xist up regulation are not reported in wild type ESC 
differentiation experiments from other groups, in which Xist up regulation on the single X 
in XY cells or both Xs in XX cells are not observed with detectable frequency (Panning 
et al. 1997). It is not clear whether uniquely sensitive Xist RNA detection methods or 
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some aspect of the differentiation protocol explains the differing results. In addition, 
analysis of early post-implantation embryos did not reveal Xist up regulation on both Xs 
in diploid XX cells (Gayen et al. 2015). These discrepancies highlight the need for an ex 
vivo differentiation method that employs the same signaling pathways used in vivo.  
 
Figure 4.2. Models in which there is input from the number of Xs. (a) An X-linked gene 
product (green squares) is present at twice the abundance in XX ESCs/ICM than XY ESCs/ICM 
(top row). Binding of this product is dosage dependent and highly cooperative, such that it can 
assemble on only one X in XX cells (middle row). Only the X on which this product assembles is 
competent to up regulate Xist, ensuring only XX cells undergo silencing and that only one X is 
silenced (bottom row). Note that the dosage-dependent X-linked factor does not necessarily 
need to bind the X, but it does need to modulate a cooperative binding factor. (b) Two factor 
model, in which autosomal factor that marks the Xa (red squares), as outlined in Fig. 4.1b, 
preclude association of the X-linked competence factor (green squares). In both these models, 
feedback or selection, as in Fig. 4.1, could eliminate incorrectly dosage compensated cells. 
 
A second class of models that does not have input from the number of Xs relies 
on an autosomally encoded repressor (often referred to as blocking factor) to block Xist 
up regulation on one X per diploid genome (Lyon et al. 1971) (Figure 4.1). In this class 
of model, Xist up regulation could be the default state on all Xs in which Xist is not 
marked for repression. In principle, cooperative assembly could ensure that an Xist 
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repressive complex assembles on only one X per diploid genome (Nicodemi et al. 
2007). Such a mechanism could be combined with selection or feedback, as described 
above, to eliminate any cells in which Xist is up regulated on the inappropriate number 
of Xs.  
Delineating the cis-elements necessary for Xist silencing on the future Xa would 
be an important first step in identifying the putative blocking factors. Furthermore, 
understanding how these factors are controlled by the developmental signaling inputs 
that lead to Xist up regulation on the Xi and repression on the Xa is also key. For 
example, determining when in development the putative repressive complex assembles 
on Xist would be important for gaining molecular insight.  
In principle, an initial mark for Xist repression could be placed on one X at any 
point after fertilization. It could then be propagated, possibly by an independent 
mechanism, throughout subsequent developmental stages until the information is read 
out at ICM to epiblast transition. One prediction of a model in which marking occurs 
early in development would be that non-clonal XO ESC populations should exhibit Xist 
up regulation in a fraction of cells, as some proportion of the founding population should 
not have the repressive mark. XO ESCs do not exhibit Xist up regulation (Maherali et al. 
2007), suggesting that if there is a mark placed earlier in development, it requires two 
Xs to be maintained or read out. In addition, induced pluripotent stem cells derived from 
mouse embryo fibroblasts have two Xas, and random XCI occurs when these cells are 
differentiated, indicating that fertilization and transition through cleavage stages is not 
necessary for selection of the Xa and Xi. Instead, these data suggest that if there is 
molecular machinery that marks the Xa, it is active in ESCs/ICM or it is poised for 
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activity in these cells. Developmental signals that direct or accompany the ICM to 
epiblast transition would then trigger Xist up regulation on the unmarked X (if the Xa is 
marked in the ICM), or would engage the marking machinery (if it is poised in the ICM) 
and direct Xist up regulation on the unmarked X (Figure 4.2). 
 
Models with input from the number of Xs 
In contrast to models in which there is no input from the number of Xs, there are 
several models in which the number of Xs impacts the decision to up regulate Xist.  
One class of models in which the number of Xs is important in triggering Xist up 
regulation involves XX-specific nuclear organization of X-linked sequences. This class 
of models posits that the Xs take on special configurations before receipt of or in 
immediate response to cues that trigger Xist up regulation. Two types of configurations 
have been reported. First, each of the Xs in XX ESCs and ICM cells exhibits a different 
three-dimensional organization, one correlating with eventual silencing and one 
correlating with fate as the Xa (Mlynarczyk-Evans et al. 2006). It is possible that these 
two distributions of X-linked sequences represent transcriptional poising that can be 
read out in response to the developmental cues that trigger Xist up regulation. A second 
XX-specific organizational feature is the pairing of the Xs, which occurs when XX ESCs 
are differentiated (Bacher et al. 2006, Barakat et al. 2014). The transient interaction of 
the Xs is thought to promote Xist up regulation on one X, possibly by contributing to 
asymmetric distribution of factors necessary for Xist repression or up regulation. 
Heterozygous deletion of a region that is sufficient to confer pairing (as an autosomal 
transgene in male ESCs) (Bacher et al. 2006) did not adversely affect Xist up regulation 
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in XX ESCs (Barakat et al. 2014). In addition, heterokaryon experiments also indicate 
that this pairing may not be necessary for Xist up regulation. In ESC heterokaryons that 
contain one XY and one XX nucleus within a single cytoplasm, the X of the XY nucleus 
was just as likely to up regulate Xist as either of the Xs in the XX nucleus (Barakat et al. 
2014). This result strongly suggests that a diffusible factor produced in ESCs with more 
than one X plays a role in triggering Xist up regulation.  
The X contains approximately 1000 genes, and pre-XCI cells with more than one 
X have the potential to produce twice as much (or more) X-linked gene products as cells 
with a single X. As a result, pre-XCI cells with one or more than one X are 
fundamentally different in the ratio of X-linked to autosomal gene products. Other 
organisms with X dosage compensation systems use this difference to direct production 
of complexes with activity that depends on abundance of specific X-linked gene 
products (Cline et al. 1996). These complexes are key for engaging the dosage 
compensation pathway. In this way the number of Xs determines whether dosage 
compensation will occur. A similar system may be functioning in mammals. In this 
scenario, the activity of activators and repressors of Xist would be dependent on the 
X:autosome ratio.  
A dosage sensitive X-linked gene product could ensure only cells with more than 
X are competent to up regulate Xist (often referred to as competence factor) (Gartler et 
al. 1983). In this scenario the appropriate developmental cue triggers Xist up regulation 
exclusively in XX cells and on the allele not marked for repression. In male cells the 
factors that promote Xist up-regulation are not produced (and the X could independently 
be marked for repression), thereby preventing silencing of the sole X. One major 
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question raised by this scenario is how is one allele of Xist marked for repression and 
the second allele in XX cells marked for activation? What molecules are involved and is 
cooperative binding and/or a unique feature of the organization of the X in XX 
ESCs/ICM used restricted to these factors to one of two otherwise identical Xs in XX 
cells.  
A class of models to restrict Xist up regulation to only one X in XX cells 
postulates that silencing of the X results in a decrease in amounts or activity of a X-
linked dosage sensitive Xist activator. The decreased abundance of this X-linked factor 
after silencing of one X precludes up regulation of Xist on the other X in XX cells. This 
class of model relies on rapid turnover of the X-linked Xist activator, since its levels 
must drop sufficiently rapidly to preclude Xist up regulation on the remaining X.  
Rlim, also known as Rnf12, encodes an X-linked E3 ubiquitin ligase that has 
been proposed to be a dosage dependent activator of Xist expression in random XCI 
(Jonkers et al. 2009). Autosomal insertion of a Rlim/Rnf12 transgene results in Xist up 
regulation from the single X in XY ESCs and both Xs in XX ESCs. A mutation that 
eliminates ubiquitin ligase activity abolishes the ectopic Xist up regulation induced by 
the transgene, suggesting that enzymatically active RLIM/RNF12 is necessary to control 
Xist. These results are consistent with a model in which the abundance of RLIM/RNF12 
in XX cells is sufficient to facilitate Xist up regulation, while that in cells with a single X is 
not, thus ensuring Xist is only activated in cells with more than one X. Since Rlim/Rnf12 
is located approximately 500 kb away from Xist, Rlim/Rnf12 is silenced rapidly in 
response Xist up regulation on one X (Barakat et al. 2011, Kalantry et al. 2009), with the 
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resulting decrease in RLIM/RNF12 abundance potentially precluding up regulation on 
the second X.  
While this model is attractive, there are likely additional complexities at play. XX 
ESCs lacking one copy of Rlim/Rnf12 exhibit Xist up regulation on one X upon 
differentiation, suggesting that the threshold of RLIM required for Xist activation is not 
strictly linked to Rlim/Rnf12 copy number (Jonkers et al. 2009). In XX ESCs lacking both 
copies of Rlim/Rnf12 no Xist up regulation is observed in one study (Barakat et al. 
2011). However, independently derived Rlim/Rnf12 null XX ESCs exhibit activation of 
Xist from one X (Shin et al. 2014) and the same group showed RLIM/RNF12 is not 
appreciably expressed in the ICM of normal embryos and conditional Rlim/Rnf12 null 
XX embryos lacking RLIM/RNF12 in the ICM show normal XCI (Shin et al. 2014). These 
differences in the XCI phenotypes of Rlim/Rnf12 mutants in culture and in vivo suggest 
that additional factors intersect with RLIM/RNF12 in control of Xist expression. For 
example, varying genetic backgrounds or differentiation protocols may impact the 
signaling pathways and downstream effectors used to trigger Xist up regulation ex vivo. 
As a result the RLIM/RNF12 requirement may be unique to a particular differentiation 
method or a specific genetic background.  
The conflicting results of Rlim/Rnf12 mutants in ESC and mouse studies suggest 
that recapitulating XCI with ESC’s ex vivo does not necessarily reflect the mechanical 
forces, extracellular matrix contacts, and signaling pathways that the ICM may be 
receiving in vivo. While studying XCI in vivo is a more developmentally accurate 
method, having ESCs as a model system is more tractable. The Rlim/Rnf12 results 
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highlight that the XCI field needs a more developmentally accurate method of 
differentiating ESCs ex vivo, ideally one that uses the same inputs as in vivo. 
 
Non-coding RNAs as activators and repressors 
One feature of all models of XCI is the existence of an X inactivation center (XIC) 
that is required in cis for inactivation to occur (Brown et al. 1991). The XIC encodes a 
host of non-coding RNAs, including Xist, and in mouse, Tsix, which is transcribed 
antisense to Xist on the Xas in ESCs (Lee et al. 1999) and epiblast cells (Gayen et al. 
2015). Xist and Tsix regulate random choice, and mutation of either gene results in non-
random XCI. In heterozygous ESCs, Xs carrying Tsix mutations become the Xi (Lee et 
al. 1999), while those carrying Xist mutations are fated to be the Xa (Marahrens et al. 
1998). An X carrying a mutation of Xist and Tsix is always the active X (Monkhorst et al. 
2008). This epistasis suggests that Tsix lies upstream of Xist in a pathway designating 
which X will be the Xa. Thus, understanding how Tsix regulates Xist is important for 
elucidating the pathways that control Xist. The promoters of Tsix and Xist eXist in 
separate topological domains as determined by chromatin capture confirmation (Nora et 
al. 2012), suggesting that the regulatory elements of the two promoters work 
independently with little to no physical contact. In this scenario, these two non-coding 
RNAs would function in cis to regulate each other’s expression without necessarily 
altering the interaction between distant regulatory elements (Navarro et al. 2005).  
Because Tsix could negatively regulate Xist, either at the transcriptional and/or 
post-transcriptional level, it is an attractive candidate for a factor that could silence Xist 
on the X fated to be the Xa (Sado et al. 2005). It is not absolutely crucial for Xist 
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silencing, as Tsix mutant XY ESCs and embryos can down regulate Xist (Ohhata et al. 
2006) and homozygous Tsix mutant ESCs and embryos can also silence Xist on one X 
(Lee et al. 2002). A fraction of Tsix mutant XY cells in the epiblast show Xist up-
regulation (Gayen et al. 2015), suggesting that Tsix is necessary for reliable Xist 
silencing and may function as a rheostat. Careful evaluation of heterozygous Tsix 
mutant mice showed that Xist is up regulated on the wild-type X and the mutant X in 
some cells of the epiblast. Xist up-regulation exhibits different kinetics on the two Xs in 
these cells, occurring later on the Tsix mutant X (Gayen et al. 2015). The cells 
expressing both copies of Xist are not detected later in development, and increased cell 
death and decreased proliferation appear to be responsible for eliminating this 
population. Together these data in male and female embryos suggest that Tsix plays a 
role in silencing Xist on Xa, but that the initial choice of which X to silence is not 
influenced by Tsix. 
An additional non-coding RNA lies within the Xist gene itself. This Xist antisense 
transcript is embedded within the first exon of Xist and is co-expressed with Xist from 
the Xi (Sarkar et al. 2015). When this antisense transcript is truncated without disrupting 
Xist, induction of Xist is diminished by ∼90%, and silencing of the Xi is impaired. Thus, 
in contrast to Tsix, this antisense Xist transcript activates Xist in cis.  
Jpx and Ftx, two noncoding RNA encoding genes lie upstream of the Xist 
promoter and inhabit the Xist topologically associated domain (Nora et al. 2012). Both 
Jpx and Ftx appear to be activators of Xist, since individual deletion of these genes 
results in either less robust Xist expression (Ftx) or absence of Xist RNA (Jpx) upon 
ESC differentiation (Tian et al. 2010, Churceau et al. 2011).While Jpx exhibits features 
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of an essential Xist activator in some studies, the effect of deleting Jpx may vary with 
genetic background or exhibit a genetic interaction with Ftx, as ESCs with a large 
deletion that removes Jpx and Ftx do not exhibit an XCI phenotype and do contribute to 
chimeras (Barakat et al. 2014). Like Tsix, it may be that these non-coding RNAs exhibit 
a rheostat-like function to ensure that Xist up regulation occurs reliably over a variable 
range of conditions. 
 
Linking Xist regulation to pluripotency 
The observation that Xist up regulation correlates with ESC differentiation lead to 
the idea that pluripotency transcription factors may repress Xist (Deuve et al. 2011). In 
this model, the differentiation induced decrease in abundance of pluripotency 
transcription factors relieves Xist repression on the future Xi. Support for this model 
came from genome-wide distribution studies suggesting that Xist is regulated by the 
pluripotency transcription factors OCT4, NANOG, SOX2, and ZFP42 (also known as 
REX1) (Navarro et al. 20018, Gontan et al. 2012). These factors bind in the vicinity of 
Xist in ESCs and may define potential Xist cis-regulatory elements. While deletion of the 
binding region for OCT4, NANOG, and SOX2 does not affect XCI in ESCs or in 
embryos (Minkovsky et al. 2013, Nesterova et al. 2011), it is possible that there is 
redundancy so that loss of regulation by any single cis-element does not yield a 
phenotype.  
The role of pluripotency transcription factors in regulating Xist expression may be 
more complex than initially hypothesized. Like the ICM, the cells of the epiblast are 
pluripotent (Diwan et al. 1976). In the epiblast and pluripotent stem cells derived from 
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the epiblast (epiSCs), Xist is up regulated on the Xi (Navarro et al. 2010). ESCs and 
epiSCs rely on a largely overlapping set of pluripotency transcription factors, as do the 
corresponding ICM and epiblast cells (Brons et al. 2007, Tesar et al. 2007). Thus, Xist 
up regulation is not strictly linked to developmental restriction away from pluripotency or 
absence of pluripotency transcription factors. It is likely that differences in relative 
abundance of these factors intersects with alterations mediated by developing signaling 
pathways, such as post-translational modification of these factors, to trigger the Xist up 
regulation that accompanies the transition from the ICM to epiblast. By altering growth 
factors or addition of small molecules, ESCs can be differentiated into epiSCs ex vivo, 
albeit with much slower kinetics than the ICM to epiblast transition in vivo (Li et al. 2013, 
Rao et al. 2014). Despite this difference, it may benefit the field to explore this more 
directed differentiation method as an ex vivo complement to studying the effects of 
mutations of putative Xist regulators in mice.  
The XCI field is at a particularly exciting time, when factors that regulate Xist 
expression are emerging. Despite these advances, a diverse range of models for how 
each XX cell may designate one Xa and one Xi remain feasible. These models reveal 
major themes that are critical when thinking about how two otherwise identical 
chromosomes (as is the case in inbred mouse strains) can be differentially treated in 
response to the same developmental signal. Whether XX cells use two-fold differences 
in abundance of X-linked gene  products, whether they take advantage of some unique 
feature of nuclear organization conferred by the non-coding RNAs of the XIC, what role 
autosomal gene products play, or whether all these mechanisms function in concert, our 
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knowledge of Xist activators and repressors will be central in understanding this key 
mystery of XCI. 
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